Lipocalin 2 and its receptor, megalin, as diagnostic and drug targets in early stages of Alzheimer's disease.

Project Number
EUJPND-ZonMw|AlzNederland|Neurosearch-Naudé-1722
Agency/Funding Organization
Netherlands Organisation for Health Research and Development|Alzheimer Nederland|Neurosearch Antwerp.
Funding Year
2016
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
P.J.W.
Principal Investigator Last Name
Naudé
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$50,000
Funding Organization